2020

1. M. Matsumoto, Y. Takeda and T. Seya 2020. Targeting Toll-like receptor 3 in dendritic cells for cancer immunotherapy. Expert Opinion on Biological Therapy. https://doi.org/10.1080/14712598.2020.1749260